Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for secondary iron overload in hereditary anemia
NL-OMON48585Phase 3Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of esomeprazole in Secondary Hemosiderosis and iron overload (2 arms), sponsored by University Medical Center Utrecht. Started Mar 2018; status: completed.
02
Drugs
esomeprazole
03
Conditions
Secondary Hemosiderosisiron overload
Beyond the preview
Go deeper on NL-OMON48585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48585.